PRESS RELEASE published on 09/15/2026 at 07:30, 12 days 12 hours ago Inside Information / Other news releases MaaT Pharma receives negative CHMP trend vote for MaaT013 (Xervyteg) conditional marketing authorization application in Europe. Company vows to explore options for patient access MaaT Pharma CHMP Clinical Benefit Xervyteg Negative Trend
PRESS RELEASE published on 09/15/2026 at 07:30, 12 days 12 hours ago Informations privilégiées / Autres communiqués MaaT Pharma annonce une tendance négative du CHMP pour MaaT013 (Xervyteg®) en Europe. Retour oral révéle préoccupations sur bénéfice clinique et sécurité MaaT Pharma CHMP MaaT013 Xervyteg® Tendance Négative
BRIEF published on 07/24/2026 at 12:17, 2 months 3 days ago Invus Public Equities reduces its stake in MAAT PHARMA Voting Rights Threshold Crossing Transfer Of Shares MaaT Pharma Invus
BRIEF published on 07/24/2026 at 12:17, 2 months 3 days ago Invus Public Equities réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuil Cession D'actions MaaT Pharma Invus
PRESS RELEASE published on 07/24/2026 at 12:12, 2 months 3 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities, L.P. pour MAAT PHARMA sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils MaaT Pharma Invus Public Equities
BRIEF published on 07/02/2026 at 18:35, 2 months 25 days ago Situation actuelle des actions et droits de vote de MaaT Pharma Euronext Paris Droits De Vote Biotechnologie Actions MaaT Pharma
BRIEF published on 07/02/2026 at 18:35, 2 months 25 days ago Current status of MaaT Pharma shares and voting rights Euronext Paris Voting Rights Biotechnology Actions MaaT Pharma
PRESS RELEASE published on 07/02/2026 at 18:30, 2 months 25 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital MaaT Pharma publie le nombre total d'actions et de droits de vote au 30 juin 2026 conformément à l'article 223-16 du Règlement Général de l'AMF Droits De Vote Capital Social AMF MaaT Pharma Biotechnologies
BRIEF published on 06/30/2026 at 13:13, 2 months 27 days ago La demande d'autorisation de mise sur le marché du MaaT013 de MaaT Pharma subit un revers. Maladie Du Greffon Contre L'hôte MaaT Pharma Décision Du CHMP Application Marketing Appel En Réexamen
BRIEF published on 06/30/2026 at 13:13, 2 months 27 days ago MaaT Pharma's Marketing Application for MaaT013 Faces Setback Graft-versus-Host Disease MaaT Pharma CHMP Decision Marketing Application Re-examination Appeal
Published on 09/26/2026 at 01:00, 1 day 18 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 21 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 2 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 4 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 2 hours 43 minutes ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 4 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 4 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 4 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 12 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 2 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 2 hours ago Availability of the 2026 half-year financial report
